Emergent Biosolutions EBS Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's total liabilities & equity?
- Emergent Biosolutions (EBS) reported total liabilities & equity of $1.32B in Q1 2026.
- How has Emergent Biosolutions's total liabilities & equity changed year-over-year?
- Emergent Biosolutions's total liabilities & equity decreased by 7.4% year-over-year, from $1.43B to $1.32B.
- What is the long-term trend for Emergent Biosolutions's total liabilities & equity?
- Over 5 years (2020 to 2025), Emergent Biosolutions's total liabilities & equity has grown at a -14.5% compound annual growth rate (CAGR), from $2.88B to $1.32B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.